Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation.

CNS & neurological disorders drug targets - 1 Jan 2018

Chico Lucia, Ienco Elena Caldarazzo, Bisordi Costanza, Lo Gerfo Annalisa, Petrozzi Lucia, Petrucci Antonio, Mancuso Michelangelo, Siciliano Gabriele

Abstract excerpt

OBJECTIVE: To investigate the efficacy of curcumin oral supplementation (600 mg/day, Brainoil), a natural antioxidant compound, in Amyotrophic Lateral Sclerosis (ALS). METHODS: Patients were randomized into two groups: Group A received placebo for 3 months, then Brainoil for the following 3 months, Group B took Brainoil for 6 months. The evaluations were conducted at basal (T0), after 3 months of double blinded...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Curcumin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dietary Supplements

Share to Exercise Test

Share to Hand Strength

Share to Lactic Acid

Share to Sulfhydryl Compounds

Share to Superoxide Dismutase-1

Source

Identifiers

PMID: 30033879
DOI: 10.2174/1871527317666180720162029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation.PMID 30033879Read ↗

Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies.Semantic proximity Read ↗

Oxidative Stress in Amyotrophic Lateral Sclerosis: Synergy of Genetic and Environmental FactorsSemantic proximity Read ↗

Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.Semantic proximity Read ↗

Redox profiles of amyotrophic lateral sclerosis lymphoblasts with or without known SOD1 mutations.Semantic proximity Read ↗

Oxidative stress profiles of lymphoblasts from Amyotrophic Lateral Sclerosis patients with or without known SOD1 mutationsSemantic proximity Read ↗

Oxidative stress in amyotrophic lateral sclerosisSemantic proximity Read ↗

Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients.Semantic proximity Read ↗

Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms.Semantic proximity Read ↗

Therapeutic advances in amyotrophic lateral sclerosis.Semantic proximity Read ↗

An in vitro screening cascade to identify neuroprotective antioxidants in ALS.Semantic proximity Read ↗

New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal DementiaSemantic proximity Read ↗

N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.